For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

The company’s focus will be on progressing the clinical validation of its idiopathic pulmonary fibrosis treatment.

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacture — a key step in bringing new drugs to ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...